BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 34347308)

  • 21. Diagnostic value of screening methods for the determination of antinuclear antibodies using indirect immunofluorescence on HEp-2 cells and enzyme immunoassay in autoimmune liver diseases.
    Dorofeev AS; Aleksandrova EN; Novikov AA; Saliev KG; Sandler YG; Vinnitskaya EV
    Klin Lab Diagn; 2022 Nov; 67(11):652-657. PubMed ID: 36398774
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multiplex assessment of non-organ-specific autoantibodies with a novel microbead-based immunoassay.
    Grossmann K; Roggenbuck D; Schröder C; Conrad K; Schierack P; Sack U
    Cytometry A; 2011 Feb; 79(2):118-25. PubMed ID: 21265005
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Laboratory screening of connective tissue diseases by a new automated ENA screening assay (EliA Symphony) in clinically defined patients.
    González C; García-Berrocal B; Pérez M; Navajo JA; Herraez O; González-Buitrago JM
    Clin Chim Acta; 2005 Sep; 359(1-2):109-14. PubMed ID: 15894301
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Application of linear discriminant analysis in performance evaluation of extractable nuclear antigen immunoassay systems in the screening and diagnosis of systemic autoimmune rheumatic diseases.
    Pi D; de Badyn MH; Nimmo M; White R; Pal J; Wong P; Phoon C; O'Connor D; Pi S; Shojania K
    Am J Clin Pathol; 2012 Oct; 138(4):596-603. PubMed ID: 23010715
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnostic Evaluation of ELISA and Chemiluminescent Assays as Alternative Screening Tests to Indirect Immunofluorescence for the Detection of Antibodies to Cellular Antigens.
    de Almeida Brito F; Maria Elói Santos S; Aparecida Ferreira G; Pedrosa W; Gradisse J; Cristina Costa L; Pretti Figueiredo Neves S
    Am J Clin Pathol; 2016 Mar; 145(3):323-31. PubMed ID: 27124914
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A hierarchical bivariate meta-analysis of diagnostic test accuracy to provide direct comparisons of immunoassays vs. indirect immunofluorescence for initial screening of connective tissue diseases.
    Orme ME; Andalucia C; Sjölander S; Bossuyt X
    Clin Chem Lab Med; 2021 Feb; 59(3):547-561. PubMed ID: 32352399
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of panel testing for detection of antinuclear antibody in a resource-limited setting: an appraisal.
    Minz RW; Kumar Y; Saikia B; Anand S; Varma S; Singh S
    Postgrad Med; 2016 Nov; 128(8):869-874. PubMed ID: 27494797
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of specific antinuclear antibodies in dogs using a line immunoassay and enzyme-linked immunosorbent assay.
    Bremer HD; Lattwein E; Renneker S; Lilliehöök I; Rönnelid J; Hansson-Hamlin H
    Vet Immunol Immunopathol; 2015 Dec; 168(3-4):233-41. PubMed ID: 26547884
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnostic value of screening enzyme immunoassays compared to indirect immunofluorescence for anti-nuclear antibodies in patients with systemic rheumatic diseases: A systematic review and meta-analysis.
    Jeong S; Yang D; Lee W; Kim GT; Kim HS; Ahn HS; Kim HJ
    Semin Arthritis Rheum; 2018 Oct; 48(2):334-342. PubMed ID: 29609799
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical use of anti-DFS70 autoantibodies.
    Kang SY; Lee WI; Kim MH; La Jeon Y
    Rheumatol Int; 2019 Aug; 39(8):1423-1429. PubMed ID: 30972541
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Next-Generation Autoantibody Testing by Combination of Screening and Confirmation-the CytoBead® Technology.
    Sowa M; Hiemann R; Schierack P; Reinhold D; Conrad K; Roggenbuck D
    Clin Rev Allergy Immunol; 2017 Aug; 53(1):87-104. PubMed ID: 27368807
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A comparison of a fluorescence enzyme immunoassay versus indirect immunofluorescence for initial screening of connective tissue diseases: Systematic literature review and meta-analysis of diagnostic test accuracy studies.
    Orme ME; Andalucia C; Sjölander S; Bossuyt X
    Best Pract Res Clin Rheumatol; 2018 Aug; 32(4):521-534. PubMed ID: 31174821
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection of specific antinuclear reactivities in patients with negative anti-nuclear antibody immunofluorescence screening tests.
    Hoffman IE; Peene I; Veys EM; De Keyser F
    Clin Chem; 2002 Dec; 48(12):2171-6. PubMed ID: 12446473
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-nuclear antibodies in daily clinical practice: prevalence in primary, secondary, and tertiary care.
    Avery TY; van de Cruys M; Austen J; Stals F; Damoiseaux JG
    J Immunol Res; 2014; 2014():401739. PubMed ID: 24741596
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Determination of Specificity and Pattern of Antinuclear Antibodies (ANA) in Systemic Rheumatic Disease Patients Positive for ANA Testing.
    Tipu HN; Bashir MM
    J Coll Physicians Surg Pak; 2018 Jan; 28(1):40-43. PubMed ID: 29290190
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of the LIAISON ANA screen assay for antinuclear antibody testing in autoimmune diseases.
    Ghillani P; Rouquette AM; Desgruelles C; Hauguel N; Le Pendeven C; Piette JC; Musset L
    Ann N Y Acad Sci; 2007 Aug; 1109():407-13. PubMed ID: 17785329
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The clinical significance of the dense fine speckled immunofluorescence pattern on HEp-2 cells for the diagnosis of systemic autoimmune diseases.
    Mahler M; Fritzler MJ
    Clin Dev Immunol; 2012; 2012():494356. PubMed ID: 23304189
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical Aspects of the Dense Fine Speckled Pattern in Indirect Immunofluorescence-Antinuclear Antibody Screening and Its Association with DFS70 Autoantibodies.
    La Jeon Y; Kang SY; Lee WI; Kim MH
    Ann Clin Lab Sci; 2019 Sep; 49(4):496-502. PubMed ID: 31471339
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Autoantibodies Against DFS70/LEDGF Exclusion Markers for Systemic Autoimmune Rheumatic Diseases (SARD).
    Seelig CA; Bauer O; Seelig HP
    Clin Lab; 2016; 62(4):499-517. PubMed ID: 27215068
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The importance of detecting anti-DFS70 in routine clinical practice: comparison of different care settings.
    Bonroy C; Schouwers S; Berth M; Stubbe M; Piette Y; Hoffman I; Devreese K; Van Hoovels L
    Clin Chem Lab Med; 2018 Jun; 56(7):1090-1099. PubMed ID: 29427547
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.